Dr. Nicholas T Potter has been appointed to the Medical Advisory Board of Epigenomics AG, a molecular diagnostics company developing and commercializing tests for the screening and diagnosis of cancer. Their lead product Epi…
Read more
Drs. Neil Quigley and Nicholas Potter co-authored a recent article comparing two assays' detection rate of the human papillomavirus (HPV) in women 30 years of age and older.
The objective of the study was to estimate high-risk (HR) HPV…
Read more